Hong Kong IPO disclosure precedents · 412 companies, 412 items
Disclosures that the five largest suppliers together account for a material share (roughly 20% or more) of total purchases, with amounts, percentages and supplier types set out.
For the years ended December 31, 2021, 2022 and 2023 and the six months ended June 30, 2024, our five largest suppliers for the respective years/period in aggregate accounted for 41.9%, 36.3%, 41.7% and 38.9% of our total purchase amount, respectively, and our largest supplier for the respective years/period contributed 15.3%, 8.0%, 11.7% and 13.2% of our total purchase amount, respectively.
Business · p. 280
We believe that our operation is not dependent on any particular supplier or contract manufacturer, since: (i) during the Track Record Period, we maintained multiple suppliers to avoid over-reliance on any of suppliers.
The purchases from our top five suppliers in each year/period during the Track Record Period were RMB52.8 million, RMB75.0 million, RMB60.1 million and RMB27.1 million, respectively, representing 61.2%, 52.5%, 37.1% and 40.1% of our total cost of sales in the same years/period, respectively.
Business · p. 231
Our Directors confirm that we had not experienced any significant material fluctuation in prices set by our suppliers, material breach of contract on the part of our suppliers or delay in delivery of our orders from our suppliers during the Track Record Period.
Business · p. 233
We typically obtain quotations from at least three suppliers, in order to ensure supply stability and optimal procurement cost control, whereas we may source those components which we believe substitute suppliers can be easily identified.
Purchases from our five largest suppliers in each year or period during the Track Record Period amounted to RMB199.5 million, RMB241.6 million, RMB253.9 million and RMB304.9 million and accounted for 24.9%, 19.5%, 15.9% and 24.6% of our total purchases for the respective periods, with the purchases from the largest supplier in each year or period during the Track Record Period contributing 7.8%, 5.4%, 4.7% and 8.0% during the same periods, respectively.
Business · p. 191
We ultimately engage one or two suppliers from our list of qualified suppliers for each type of key food ingredients or other consumables.
Business · p. 189
We may from time to time enter into strategic cooperative agreements with key suppliers in order to strengthen our business relationships with them and further secure sufficient supplies.
Purchases from our five largest suppliers in each year/period during the Track Record Period amounted to RMB175.8 million, RMB194.0 million, RMB262.3 million and RMB153.2 million in 2021, 2022, 2023 and the six months ended June 30, 2024, respectively, representing 52.8%, 50.5%, 53.6% and 52.3% of our total purchases for the same periods.
Summary · p. 10
Purchases from our largest supplier in each year/period during the Track Record Period amounted to RMB62.3 million, RMB79.2 million, RMB111.3 million and RMB53.0 million, respectively, representing 18.7%, 20.6%, 22.7% and 18.1% of our total purchases for the same period, respectively.
Business · p. 248
We have put in place a centralized supplier management system and implemented a rigorous supplier selection and evaluation procedure.
Amounts paid to our five largest suppliers in each of 2021, 2022 and 2023 and the six months ended June 30, 2024 accounted for 14.8%, 15.4%, 27.7%, and 37.4%, respectively, of our purchases from continuing operations during the same years/ period.
Summary · p. 11
We believe we have sufficient alternative suppliers for our business that can provide us with substitutes of comparable quality and prices.
Amounts paid to our five largest suppliers of each of the years ended December 31, 2021, 2022 and 2023 and the six months ended June 30, 2024 accounted for approximately 96.8%, 98.8%, 97.4% and 98.6% of our total purchase for each of the respective year/period.
Summary · p. 10
During the Track Record Period, our major suppliers were all gold suppliers and commercial banks who provided gold loans to us.
Summary · p. 10
None of our Directors, their close associates or any Shareholder (who or which, to the knowledge of our Directors, owns more than 5% of the issued share capital of our Company) had any interest in any of our five largest suppliers of each year/period during the Track Record Period.
Purchases from our five largest suppliers, calculated on the group level with entities controlled by the same group combined together, for 2021, 2022, 2023 and the six months ended June 30, 2024 were RMB217.1 million, RMB139.1 million, RMB139.2 million and RMB60.2 million, respectively, representing 54.5%, 56.4%, 60.6% and 59.7% of our total purchase cost for the respective period.
Summary · p. 10
We do not have substantial reliance on any single supplier. We believe that we have long and stable relationships with our existing major suppliers. According to CIC, it is common for pharmaceutical companies in China to have high supplier concentrations.
In the years ended December 31, 2021, 2022 and 2023 and the five months ended May 31, 2024, purchases from our five largest suppliers amounted to RMB151.7 million, RMB221.4 million, RMB95.6 million and RMB25.6 million, respectively, accounting for 44.1%, 55.4%, 33.6% and 39.7%, respectively of our total purchases for the same years/periods.
Business · p. 311
In each year/period of the Track Record Period, purchases from our largest supplier amounted to RMB65.8 million, RMB138.9 million, RMB42.4 million and RMB13.0 million, respectively, accounting for 19.1%, 34.7%, 14.9% and 20.2%, respectively, of our total purchases for the same years/periods.
Business · p. 311
During the Track Record Period, we normally collaborated with multiple suppliers for one type of raw materials to reduce our reliance on a single supplier.
Transaction amounts, which represent our purchase amounts from the supplier, from our five largest suppliers in each year/period during the Track Record Period represented 20.7%, 30.9%, 27.7% and 28.1% of our total transaction amounts for the year ended December 31, 2021, 2022, 2023 and the four months ended April 20, 2024, respectively.
Business · p. 239
The decrease in the number of our manufacturing partners during the Track Record Period was primarily because we consolidated our manufacturing partnerships to streamline operations, adopted strategic sourcing by choosing fewer but more reliable and higher-quality manufacturing partners, and achieved supply chain optimization for efficiency.
Business · p. 239
We have established and maintained long-term and stable relationships with our key manufacturing partners, with the duration of such relationships ranging from two to ten years.
Our purchases from our largest supplier in each of the years ended December 31, 2022 and 2023 and the five months ended May 31, 2024 amounted to RMB21.5 million, RMB25.8 million, and RMB25.6 million, accounting for 18.3%, 15.4%, and 29.7% of our total purchases, respectively; purchases from our five largest suppliers in aggregate in each of the years ended December 31, 2022 and 2023 and the five months ended May 31, 2024 amounted to RMB45.5 million, RMB57.4 million, and RMB39.3 million, accounting for 38.8%, 34.2%, and 45.5% of our total purchases, respectively.
Summary · p. 17
For example, we currently procure all products utilized in combination therapies, such as Xeloda, for R&D purpose at a fair and reasonable market price from a specific supplier, which is a distributor purchasing products from pharmaceutical companies.
Business · p. 381
Based on the above, our Directors believe that adequate alternative sources for such products exist and we in general do not rely on any particular supplier.
The purchase amounts from our largest supplier in each of 2021, 2022 and 2023 and the four months ended April 30, 2024 accounted for 7.0%, 9.7%, 11.0% and 11.8%, respectively, of our total purchase amount during those respective periods.
Business · p. 229
The aggregate purchase amounts from our five largest suppliers in each of 2021, 2022 and 2023 and the four months ended April 30, 2024 accounted for 31.0%, 33.5%, 33.2% and 28.5%, respectively, of our total purchase amount during those respective periods.
Business · p. 229
For key raw materials and packaging materials, we collaborate with multiple suppliers to reduce the concentration risks associated therewith.
Our transaction amounts with our largest supplier for the three years ended December 31, 2023 and the three months ended March 31, 2024 accounted for 36.1%, 16.3%, 5.9% and 8.0%, respectively, of our total purchase during those periods.
Summary · p. 4
We have established and maintained stable and good relationships with our five largest suppliers for each year during the Track Record Period, having a relationship of 6 years or above with a majority of them.
Business · p. 302
We have a vast number of suppliers for sourcing network and bandwidth services, server and storage services and IDC services and they are scattered across different regions in China and overseas.
In 2021, 2022, 2023 and the three months ended March 31, 2024, purchases from our five largest suppliers accounted for 39.8%, 50.3%, 45.1%, and 37.4% of our total purchase, respectively, with purchases from our largest supplier comprising 18.0%, 16.9%, 18.0%, and 17.4% of our total purchase during the same periods.
Business · p. 213
This approach ensures that we maintain sufficient production capacity while mitigating the risk of potential performance issues associated with a single supplier.
Business · p. 207
For our key product series, we typically engage in long-term cooperation with two to three contract manufacturers while also enjoying the flexibility to choose alternative supplies as needed to ensure continuous supply and maintain quality.
In 2022, 2023 and the three months ended March 31, 2024, our purchases from our five largest suppliers in each year/period during the Track Record Period in the aggregate accounted for 51.8%, 38.8% and 37.3% of our total purchases in the respective year/period, respectively, and purchases from our largest supplier in each year/period during the Track Record Period alone accounted for 20.8%, 10.0% and 9.6% of our total purchases in the respective year/period, respectively.
Business · p. 375
A majority of our raw materials are widely available, and we are able to purchase them from numerous suppliers according to our product development plans.
Business · p. 375
We plan to explore opportunities to vertically integrate our supply chain to secure upstream resources and improve our profitability by investment in or partnerships with selective and qualified raw material suppliers.
Charges from our five largest suppliers in each year or period during the Track Record Period accounted for 68.2%, 50.9%, 43.4% and 58.8%, respectively, of our total purchase amount for the respective year or period.
Summary · p. 14
Shanghai International Science and Technology Corp., Ltd served as our import agent.
Purchases from our five largest suppliers combined in each year of the Track Record Period amounted to RMB1,203.9 million, RMB1,309.2 million and RMB1,273.0 million, accounting for 60.9%, 57.2% and 51.5% of our total purchases for the respective years, and purchases from our largest supplier alone accounted for 20.5%, 14.8% and 15.7% of our total purchases for the respective years.
Business · p. 277
We believe we have sufficient alternative suppliers for pharmaceutical and healthcare products that can provide us with substitutes of comparable quality and prices.
Business · p. 278
In 2021, 2022 and 2023, purchases from our top five suppliers accounted for 60.9%, 57.2% and 51.5% of our total purchases, respectively, and purchases from our largest supplier alone accounted for 20.5%, 14.8% and 15.7% of our total purchases during each of those years, respectively.
During the Track Record Period, our five largest suppliers in each year of the Track Record Period accounted for approximately 64.2%, 55.4% and 54.9% of our total purchase amounts, respectively. During the same periods, our largest supplier in each year of the Track Record Period accounted for approximately 29.4%, 21.1% and 16.7% of our total purchase amounts, respectively.
Summary · p. 8
None of our Directors or their close associates, or any, Shareholders who (to the best knowledge of our Directors are beneficially interested in 5% or more of the issued share capital of our Company) or their respective close associates had any interest in any of our five largest suppliers in each year of the Track Record Period.
Business · p. 301
During the Track Record Period and up to the Latest Practicable Date, our Group had not experienced any major disruption in business due to material delays or defaulting payments in respect of purchases we made from our top suppliers, and there has been no material breaches of the supply agreements with our top suppliers which may have or have had a significant effect on the Group’s business operations or financial condition.
For each year during the Track Record Period, purchases from our top five suppliers accounted for 27.5%, 41.4% and 33.7% of our total purchases in 2021, 2022 and 2023, respectively.
Summary · p. 12
For each year during the Track Record Period, purchases from our largest supplier accounted for 8.5%, 21.9% and 12.2% of our total purchases in the same periods, respectively.
Purchase amount from our five largest suppliers in each year of the Track Record Period amounted to RMB279.0 million, RMB336.0 million and RMB308.0 million, respectively, representing 72.6%, 65.9% and 63.0% of our total purchase amount for the same years, respectively; purchase amount from our largest supplier in each year amounted of the Track Record Period to RMB152.6 million, RMB136.7 million and RMB148.4 million, respectively, representing 39.7%, 26.8% and 30.4% of our total purchase amount for the same years, respectively.
Business · p. 328
Our Directors are of the view that we would be able to engage similar suppliers at comparable costs if the aforementioned procurement agreement with Supplier A was terminated or expired, given the network resources transacted thereunder being available from other similar telecommunications companies, as well as our large-volume need for the same.
Our purchases from our five largest suppliers in each year during the Track Record Period in aggregate accounted for 51.0%, 51.5% and 51.4% of our total purchases, for the respective years.
Summary · p. 9
Given the intensely specialized nature of the manufacturing process, particular design parts are typically produced by single, qualified suppliers.
Business · p. 208
However, we do not believe we have material reliance on our key suppliers, as commercially viable alternatives exist for components provided by all of our key suppliers and can be implemented into existing airframes following FAA program approval (if needed).